Vedant Poly Fabs SME IPO opens today; GMP at 16%, check key details

Vedant Poly Fabs' initial public offering (IPO) is opening for subscription today, November 2, on the NSE SME platform. Ahead of the issue opening, the IPO commands a grey market premium (GMP) of around 16%, indicating expectations of a potential listing gain over the issue price.

The Vedant Poly FabsIPO is a book-built issue worth Rs 56.68 crore. It comprises a fresh issue of 54.26 lakh equity shares aggregating to Rs 51.01 crore and an offer for sale (OFS) of 6.04 lakh shares worth Rs 5.67 crore.

The IPO will remain open for subscription from November 2 to November 4, 2026. The basis of allotment is expected to be finalised on November 5, while the shares are tentatively scheduled to list on the NSE SME platform on November 9.


The company has fixed the IPO price band at Rs 88–94 per share. The lot size is 1,200 shares. Retail investors are required to apply for a minimum of two lots, or 2,400 shares, translating into an investment of Rs 2,25,600 at the upper end of the price band. For high-net-worth individual (HNI) investors, the minimum application size is three lots, or 3,600 shares, amounting to Rs 3,38,400.

Affinity Global Capital Market Pvt. Ltd. is the book-running lead manager to the issue, while Cameo Corporate Services Ltd. is the registrar.

Vedant Poly FabsIPO GMP today

Vedant Poly FabsIPO was commanding a grey market premium (GMP) of Rs 15 per share, or around 16%, over the upper price band of Rs 94. This indicates an estimated listing price of Rs 109 per share.

However, GMP is an unofficial indicator of investor sentiment and does not guarantee the actual listing price or returns.

Also Read | FPI buying returns to Dalal Street as global investors rethink AI bets

IPO objects of the issue

Vedant Poly Fabs plans to utilise the net proceeds from the IPO primarily to meet its incremental working capital requirements, for which it has earmarked Rs 24.61 crore. The company will allocate Rs 8 crore towards the prepayment or repayment of certain outstanding secured and/or unsecured borrowings. Another Rs 6.51 crore will be used for capital expenditure, including the purchase and installation of plant and machinery at its existing manufacturing facility. The remaining proceeds will be utilised for general corporate purposes and to meet issue-related expenses.

About Vedant Poly Fabs Ltd.

Incorporated in December 2018, Vedant Poly Fabs Ltd. manufactures flexible packaging materials and supplies them to businesses across India through a business-to-business (B2B) model. Its product portfolio includes three-layer and five-layer low-density (LD) films, shrink films, barrier films, printed laminates, and milk and oil pouches. These products cater to industries such as food and beverages and other consumer goods.

Since commencing operations, the company has expanded its product range, strengthened its manufacturing capabilities and established dedicated teams for sales, design, production, logistics and dispatch.

In March 2026, Vedant Poly Fabs further enhanced its manufacturing capacity by installing lamination, slitting and pouching machines. It also added a reprocessing unit to improve resource utilisation and recycle manufacturing waste.

The company's manufacturing operations follow an integrated process, covering raw material procurement, film extrusion, printing, lamination, slitting, quality control, packaging and dispatch.

As of June 30, 2026, the company had 61 employees across its manufacturing facility and office operations. These included directors, key managerial personnel and senior managerial personnel responsible for business operations, compliance, administration, marketing and accounting.

Disclaimer: The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here